Pain conditions are a major health problem in the US and lead to medical morbidity and a reduced quality of life for millions of Americans. Chronic neuropathic pain conditions are especially difficult to treat. A largely unaddressed challenge is how the transition from acute pain to chronic neuropathic pain occurs and how to prevent and reverse this transition in patients. Spinal cord synaptic plasticity and long-term potentiation (LTP) have been strongly implicated in chronic neuropathic pain development. Accumulating evidence also points to an important role of glial cells in the pathogenesis of neuropathic pain. Astrocytes are the most abundant cell type in the CNS and maintain the homeostasis of the CNS. It is well established that astrocytic hemichannels such as connexin-43 (Cx43) constitute an important pathway for gliotransmitter release. Although Cx43 was typically thought to regulate gap junction communication between astrocytes, this function could be switched to paracrine signaling via ATP and glutamate release under injury conditions. Our central hypothesis is hemichannels-mediated gliotransmitter release after nerve injury contributes to transition from acute pain to chronic neuropathic pain by modulating spinal cord synaptic plasticity and LTP. We will test our central hypothesis by addressing the following 4 specific aims:
Aim 1 will test the hypothesis that spinal nerve injury increases glutamate and ATP release from spinal cord astrocytes;
Aim 2 will test the hypothesis that Cx43-mediated astrocytic ATP release plays a chief role in microglia activation and microgliosis in the spinal cord after spinal nerve injury;
Aim 3 will determine the role of Cx43-medicated astrocytic gliotransmitter release in spinal cord synaptic plasticity and LTP after nerve injury;
Aim 4 will define the role o astrocytic Cx43 in neuropathic pain development and maintenance after nerve injury. This proposal will involve formation of an innovative partnership between Dr. Ji, a pain scientist with expertise in studying neuronal-glial interactions and neural plasticity in neuropathic pain, and Dr Nedergaard with expertise in studying astrocytic ATP and glutamate release after spinal cord injury and stroke. This application will employ a multidisciplinary approach including the use of inducible transgenic mice with genetically modified astrocytes, in vivo imaging of ATP release (bioluminescence) and microglia motility and Ca2+ changes (2-photon) in the spinal cord, behavioral testing of evoked and ongoing neuropathic pain after nerve injury, and ex vivo and in vivo electrophysiology in the spinal cord. The proposed studies will provide a step-by-step analysis of neuron- glia interactions initiated by nerve injury and may comprise an efficient means to prevent and treat chronic pain.

Public Health Relevance

Dysfunction of spinal cord astrocytes after nerve injury may contribute to the development of neuropathic pain via releasing gliotransmitters such as ATP and glutamate. We will employ multidisciplinary approaches such as transgenic mice with genetically modified astrocytes, two-photon imaging, behavioral analyses of evoked and ongoing pain, and ex vivo and in vivo electrophysiology to define the role of connexin-43 hemichannels expressed by spinal astrocytes in regulating synaptic plasticity and neuropathic pain. Given the incomplete understanding of neuropathic pain mechanisms and insufficient treatment of neuropathic pain, this application will provide new information about transition of acute pain to chronic neuropathic pain and offer new strategy for neuropathic pain management.

Agency
National Institute of Health (NIH)
Type
Research Project (R01)
Project #
5R01DE022743-03
Application #
8706695
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Wan, Jason
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Duke University
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
City
Durham
State
NC
Country
United States
Zip Code
27705
Park, Chul-Kyu; Xu, Zhen-Zhong; Berta, Temugin et al. (2014) Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1. Neuron 82:47-54
Cao, De-Li; Zhang, Zhi-Jun; Xie, Rou-Gang et al. (2014) Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2. Exp Neurol 261:328-36
Berta, Temugin; Park, Chul-Kyu; Xu, Zhen-Zhong et al. (2014) Extracellular caspase-6 drives murine inflammatory pain via microglial TNF-? secretion. J Clin Invest 124:1173-86
Takano, Takahiro; He, Wei; Han, Xiaoning et al. (2014) Rapid manifestation of reactive astrogliosis in acute hippocampal brain slices. Glia 62:78-95
Ji, Ru-Rong; Xu, Zhen-Zhong; Gao, Yong-Jing (2014) Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov 13:533-48
Liu, Xing-Jun; Zhang, Yanli; Liu, Tong et al. (2014) Nociceptive neurons regulate innate and adaptive immunity and neuropathic pain through MyD88 adapter. Cell Res 24:1374-7
Thrane, Alexander S; Rangroo Thrane, Vinita; Nedergaard, Maiken (2014) Drowning stars: reassessing the role of astrocytes in brain edema. Trends Neurosci 37:620-8
Lee, Jun-Ho; Park, Chul-Kyu; Chen, Gang et al. (2014) A monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch relief. Cell 157:1393-404
Lu, Ying; Jiang, Bao-Chun; Cao, De-Li et al. (2014) TRAF6 upregulation in spinal astrocytes maintains neuropathic pain by integrating TNF-? and IL-1? signaling. Pain 155:2618-29
Chen, Gang; Park, Chul-Kyu; Xie, Rou-Gang et al. (2014) Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice. Brain 137:2193-209

Showing the most recent 10 out of 20 publications